In a landmark move for the medtech industry, Carlyle Group (NASDAQ) has announced its decision to acquire Baxter International Inc.’s (NYSE) Kidney Care segment for a substantial $3.8 billion. This transaction will see the segment rebranded as Vantive and marks a significant shift in the global kidney care market. The acquisition, slated to close in […]
Ethos therapy Varian : Varian, a cancer care technologies developer, has introduced Ethos therapy, an artificial intelligence (AI)-powered personalized cancer care delivery system in radiation oncology, as per the latest medical device news. Ethos therapy, designed to deliver adaptive treatment in a typical 15-minute timeslot, will target the tumor, reduce dose to healthy tissue and […]
